BNGO(4h) Technical ChartBionano Genomics, Inc.
Formation: Falling Wedge Pattern
SL-6.56$
TP1-9.63$
TP2-11.65$
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−91.92 MXN
−3.95 B MXN
613.44 M MXN
85.45 M
About Bionano Genomics, Inc.
Sector
Industry
CEO
Robert Erik Holmlin
Website
Headquarters
San Diego
Founded
2003
FIGI
BBG00Z0GFPN9
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BNGO is 5.82 MXN — it has increased by 0.69% in the past 24 hours. Watch BIONANO GENOMICS, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange BIONANO GENOMICS, INC stocks are traded under the ticker BNGO.
BNGO stock has fallen by −4.43% compared to the previous week, the month change is a −34.75% fall, over the last year BIONANO GENOMICS, INC has showed a −75.60% decrease.
We've gathered analysts' opinions on BIONANO GENOMICS, INC future price: according to them, BNGO price has a max estimate of 53.98 MXN and a min estimate of 19.28 MXN. Watch BNGO chart and read a more detailed BIONANO GENOMICS, INC stock forecast: see what analysts think of BIONANO GENOMICS, INC and suggest that you do with its stocks.
BNGO stock is 4.24% volatile and has beta coefficient of 2.98. Track BIONANO GENOMICS, INC stock price on the chart and check out the list of the most volatile stocks — is BIONANO GENOMICS, INC there?
Today BIONANO GENOMICS, INC has the market capitalization of 545.67 M, it has increased by 16.75% over the last week.
Yes, you can track BIONANO GENOMICS, INC financials in yearly and quarterly reports right on TradingView.
BIONANO GENOMICS, INC is going to release the next earnings report on Nov 7, 2024. Keep track of upcoming events with our Earnings Calendar.
BNGO earnings for the last quarter are −4.40 MXN per share, whereas the estimation was −7.62 MXN resulting in a 42.21% surprise. The estimated earnings for the next quarter are −3.89 MXN per share. See more details about BIONANO GENOMICS, INC earnings.
BIONANO GENOMICS, INC revenue for the last quarter amounts to 143.07 M MXN, despite the estimated figure of 147.08 M MXN. In the next quarter, revenue is expected to reach 152.84 M MXN.
BNGO net income for the last quarter is −297.58 M MXN, while the quarter before that showed −520.75 M MXN of net income which accounts for 42.86% change. Track more BIONANO GENOMICS, INC financial stats to get the full picture.
No, BNGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 6, 2024, the company has 344.00 employees. See our rating of the largest employees — is BIONANO GENOMICS, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIONANO GENOMICS, INC EBITDA is −1.65 B MXN, and current EBITDA margin is −348.10%. See more stats in BIONANO GENOMICS, INC financial statements.
Like other stocks, BNGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIONANO GENOMICS, INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIONANO GENOMICS, INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIONANO GENOMICS, INC stock shows the sell signal. See more of BIONANO GENOMICS, INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.